Cite
HARVARD Citation
McClung, M. et al. (2018). Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double‐Blind, Phase 2, Parallel Group Study. Journal of bone and mineral research. pp. 1397-1406. [Online].